McKesson to pay $150M to settle suspicious order practices lawsuit

San Francisco-based McKesson has agreed to settle claims with the Department of Justice, Drug Enforcement Administration and various U.S. Attorney’s offices alleging suspicious order reporting practices for controlled substances by paying $150 million and suspending at least three distribution center registrations for two years, according to Reuters.

McKesson has suspended the DEA registrations for specific products at its Aurora, Colo., Livonia, Mich., Washington Courthouse, Ohio, and Lakeland, Fla., distribution warehouses for between one and three years, according to McKesson’s 8-K filing with the SEC.

The company’s Landover, Md., distribution center is also being investigated, according to Reuters.

McKesson to pay $150M to settle suspicious order practices lawsuit

More articles on health IT:

Next Up in Health IT

JAMA’s new journal targets health AI’s evidence gap

Bon Secours Mercy Health added 10,400 appointment slots: what other health systems can learn

AI and pancreatic cancer detection: 4 notes

More articles on health IT:

Next Up in Health IT

Join the 500,000+ healthcare executives who start their day with Becker's